Where Is Cannabis Legal In Europe? https://t.co/7MCJRd9BsG https://t.co/7MCJRd9BsG ...

Alan Brochstein, CFA, is one of the first investment professionals to focus exclusively on the cannabis industry. Alan got his start as a financial professional in the securities industry in 1986, managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent consulting to registered investment advisors. He is also the managing partner of New Cannabis Ventures, a leading provider of relevant financial information in the cannabis industry si ...

The Kings Of CBD Are Now Cooking Up Plans To Make Billion-Dollar Meds From Cannabis And Mushrooms https://t.co/TjLUth5XI5 https://t.co/TjLUth5XI5 ...

Industry Overview - The cannabis sector has experienced a steady decline, but there are indications that the future for marijuana stocks could improve [1] - Many companies are showing success and profitability, yet this has not significantly impacted the public sector [1] - The industry is awaiting federal reforms, such as rescheduling or banking reform, to create a more efficient and compliant market [2] Market Potential - Almost every state in the US has legalized cannabis, along with several global regions, indicating a growing market [2] - Canada is also a significant market, and there is a positive outlook for potential gains in the cannabis sector [3] Company Highlights - **Trulieve Cannabis Corp.**: Operates as a cannabis retailer, cultivating, processing, and distributing cannabis products. The company has filed a shelf registration statement with the SEC [4][6] - **Green Thumb Industries Inc.**: Manufactures and sells cannabis products for medical and adult use in the US, operating through Retail and Consumer Packaged Goods segments [6] Upcoming Events - Trulieve will hold a Q2 2024 conference call on August 6 to discuss its results [6] - Green Thumb Industries will release its second quarter 2025 financial results after the market closes on August 6, 2025, followed by a conference call [9]

Market Overview - The Legal Cannabis Market has grown from USD 33.52 billion in 2024 to USD 42.91 billion in 2025, with a projected value of USD 144.18 billion by 2030, reflecting a compound annual growth rate (CAGR) of 27.52% [2][11]. - The market evolution is driven by legislative changes, consumer behavior, and technological advancements [2]. Industry Dynamics - Legislative changes and increasing consumer acceptance have led to a diverse range of products, including extracts and edibles, while regulatory bodies are enhancing quality control measures [3]. - Vertical integration and partnerships are essential for achieving scale and distribution advantages, with advances in cultivation improving yields and consistency [4]. - Federal developments are fostering optimism regarding interstate commerce and harmonized licensing and taxation frameworks [5]. Investment Trends - There is a noticeable shift towards ancillary services and strategic mergers and acquisitions, which are reshaping competitive landscapes and refining value creation across the supply chain [6]. - Decision-makers are gaining strategic insights to identify opportunities amid evolving consumer preferences and technological advancements [6]. Tariff Impact - New tariff structures in 2025 have increased costs for cultivation and processing, leading to reassessments of manufacturing locations and supplier networks [8]. - Retailers are facing margin pressures due to increased duties on imported machinery and packaging components, often passing costs to consumers [9]. - Regional operators are diversifying sourcing strategies to mitigate future tariff effects, fostering collaborative partnerships to maintain resilience [9]. Key Report Attributes - The report spans 193 pages, covering the forecast period from 2025 to 2030, with an estimated market value of USD 42.91 billion in 2025 and a forecasted value of USD 144.18 billion by 2030 [11].

Core Insights - Cresco Labs (CRLBF) is facing persistent challenges in the U.S. cannabis market despite being a leading vertically integrated operator [1][2] - The company reported a 10% year-over-year decline in revenues for Q1 2025, totaling $165.8 million, amid restrictive federal laws and fragmented state regulations [3][9] - Adjusted gross margin decreased to 49.3%, down 220 basis points year-over-year, while adjusted EBITDA margins contracted to nearly 22% from 28.8% [4][9] - The company anticipates further revenue pressure in Q2 due to a mandatory system transition in Illinois, despite ongoing expansion efforts [5][9] - Cresco's stock has declined 24% year-to-date, contrasting with a 6% rise in the industry [8] Company Performance - Cresco's revenues are solely generated from the U.S., making it vulnerable to domestic market challenges [2] - The company generated $30 million in operating cash flow, but profitability is under pressure from rising costs [4] - Loss estimates for 2026 and 2027 have widened over the past 60 days, indicating ongoing financial difficulties [11] Competitive Landscape - Cresco faces stiff competition from peers like Aurora Cannabis, Canopy Growth, and Tilray Brands, which are also pursuing expansion and cost-optimization strategies [6] - Competitors are diversifying their revenue streams internationally, giving them an edge over Cresco, which remains reliant on the saturated U.S. market [7] Future Outlook - The company's turnaround is contingent on a broader regulatory shift in the U.S., which remains uncertain in the near term [12] - Despite operational discipline and free cash flow generation, the stock is considered to have limited upside and elevated risk for conservative investors [12]

TALLAHASSEE, Fla., July 11, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the launch of Redemption Cannabis products at Trulieve dispensaries in West Virginia.Redemption Cannabis, founded by industry advocate Ryan Basore, reinvests a portion of every sale to support individuals and families impacted by cannabis prohibition laws. Redemption's mission stems from Basore's commitme ...

Weed Rx: “Pharmaceutical cannabis is the biggest future for cannabis,” says Joel Stanley (left, with his brother Jared), founder of Ajna BioSciences, which has a botanical drug in the FDA pipeline. https://t.co/Q2rTHfUQwO https://t.co/Q2rTHfUQwO ...

Where Is Cannabis Legal In Europe? https://t.co/hnhQuy6l8s https://t.co/hnhQuy6l8s ...

Legal Status - Cannabis legality in Europe is being discussed [1] Industry Focus - The report focuses on the European cannabis market [1]